1. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021 Subject(s): Antipsychotic Agents -- standardsFrail Elderly -- statistics & numerical dataGovernment RegulationNursing Homes -- legislation & jurisprudenceVulnerable Populations -- legislation & jurisprudenceUnited StatesUnited States. Department of Health and Human ServicesCenters for Medicare & Medicaid Services (U.S.)
